ANTI-NUCLEAR ANTIBODY TESTING MARKET ANALYSIS

Regional Analysis

Global Anti-nuclear Antibody Testing market: Regional Insights

The largest market for anti-nuclear antibody testing is North America, followed by Europe while Asia Pacific is the fastest growing market. However, Middle East and Africa are expected to show limited market growth due to lack of awareness of medical advancements and treatments for diseases associated with anti-nuclear antibody. The dominance of North American anti-nuclear antibody testing market is attributable to several factors such as a rise in the geriatric population and increasing incidence of autoimmune disorders such as Rheumatoid arthritis, SLE, etc. For instance, the American Autoimmune Related Disease Association (AARDA) has declared a list of more than 100 types of autoimmune disorders prevailing in the U.S. The market growth of Asia Pacific is expected to continue at a fast pace as a result of rising population, rise in the incidence of autoimmune disorders, growing investments in R&D, and technological advancements in health infrastructure.